Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ADCYAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TIMM23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
MGST3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEX5L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SFRP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC219690 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
LOC101929741 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC102724487 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR3681HG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101928314 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNASE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00309 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRND - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FHL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASCL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on